News

ATTAIN-1 is the second trial this year to show positive results with once-daily orforglipron, with best results seen at the ...
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 shots.
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
GLP-1 receptor agonists are associated with risk reductions for dozens of diseases and conditions in addition to rapid weight ...
It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting ...
Claire Reed bought medication online to lose weight before a vacation, but claims she was passing out and too nauseous to eat ...
Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...